Not Signed In -
Pancreas/pancreatic Diseases And Disorders |
Pancreas |
The pancreas is an organ in the digestive system that serves two major functions: exocrine - it produces pancreatic juice containing digestive enzymes. endocrine - it produces several important hormones, including insulin. Anatomy The pancreas is located posterior to the stomach and in close association with the duodenum. In humans, the pancreas is a 6-10 inch elongated organ in the abdomen located retroperitoneal. It is often described as having three regions: a head, body and tail. ...
Wikipedia - [full article]
Pancreas/pancreatic Diseases And Disorde... Clinical Trials
- 3-AP as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma (Cancer) of the Pancreas
ClinicalTrials.gov Identifier: NCT00085371 - Active, not recruiting
adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ...
- Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00058201 - Recruiting
acinar cell adenocarcinoma of the pancreas; duct cell adenocarcinoma of the pancreas; stage I pancreatic cancer; stage II pancreatic cancer; ...
- DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas
ClinicalTrials.gov Identifier: NCT00003951 - Active, not recruiting
recurrent pancreatic cancer; duct cell adenocarcinoma of the pancreas; stage IV pancreatic cancer; adenocarcinoma of the pancreas
- Paclitaxel and Bryostatin-1 in Treating Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00031694 - Active, not recruiting
stage II pancreatic cancer; stage III pancreatic cancer; recurrent pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; ...
- Sorafenib and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00095966 - Active, not recruiting
adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ...
- Vaccine Therapy in Treating Patients With Stage I or Stage II Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00003025 - Active, not recruiting
stage I pancreatic cancer; stage II pancreatic cancer; adenocarcinoma of the pancreas
- Gemcitabine With or Without Cetuximab as First-Line Therapy in Treating Patients With Locally Advanced Unresectable or Metastatic Adenocarcinoma of the Pancreas
ClinicalTrials.gov Identifier: NCT00075686 - Active, not recruiting
adenocarcinoma of the pancreas; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00005832 - Active, not recruiting
childhood gastrointestinal cancer; stage II pancreatic cancer; stage IVA pancreatic cancer; duct cell adenocarcinoma of the pancreas; ...
- Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00088894 - Active, not recruiting
adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ...
- BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery
ClinicalTrials.gov Identifier: NCT00024362 - Active, not recruiting
stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
- Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas
ClinicalTrials.gov Identifier: NCT00079365 - Active, not recruiting
adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Cancer of the Pancreas That Cannot Be Removed by Surgery
ClinicalTrials.gov Identifier: NCT00003798 - Active, not recruiting
stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
- Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00003591 - Active, not recruiting
stage III pancreatic cancer; adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage I pancreatic cancer; stage II pancreatic cancer
- Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas
ClinicalTrials.gov Identifier: NCT00005870 - Active, not recruiting
recurrent pancreatic cancer; adenocarcinoma of the pancreas
- 3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00078975 - Active, not recruiting
adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ...
- Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
ClinicalTrials.gov Identifier: NCT00003029 - Active, not recruiting
stage III pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- ISIS 2503 in Treating Patients With Advanced Cancer of the Pancreas
ClinicalTrials.gov Identifier: NCT00005594 - Active, not recruiting
stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
- Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00005053 - Active, not recruiting
recurrent pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
- Gemcitabine With or Without Pemetrexed Disodium in Treating Patients With Unresectable Stage II, Stage III, or Stage IV Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00049426 - Active, not recruiting
stage II pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; stage IVA pancreatic cancer; adenocarcinoma of the pancreas
- Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas
ClinicalTrials.gov Identifier: NCT00003049 - Active, not recruiting
stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
- Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the Pancreas
ClinicalTrials.gov Identifier: NCT00020345 - Active, not recruiting
Stage IVA Pancreatic Cancer; Stage III Pancreatic Cancer; Adenocarcinoma of the Pancreas
- Bevacizumab With or Without Docetaxel in Treating Patients With Previously Treated Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00066677 - Active, not recruiting
adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00004884 - Active, not recruiting
recurrent pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
- Gemcitabine With or Without Erlotinib in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00026338 - Active, not recruiting
stage III pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma
ClinicalTrials.gov Identifier: NCT00075452 - Active, not recruiting
adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas
ClinicalTrials.gov Identifier: NCT00003216 - Active, not recruiting
stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer
- Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00058149 - Active, not recruiting
stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
- Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00100815 - Active, not recruiting
adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer
- Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00003851 - Active, not recruiting
stage II pancreatic cancer; stage III pancreatic cancer; stage IV pancreatic cancer; Nutrition; adenocarcinoma of the pancreas
- Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas
ClinicalTrials.gov Identifier: NCT00012220 - Active, not recruiting
adenocarcinoma of the pancreas; stage IVB pancreatic cancer
- Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00096070 - Active, not recruiting
adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer
- Dolastatin 10 in Treating Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00003677 - Active, not recruiting
recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
- Adjuvant Chemoradiotherapy and Interferon alfa in Treating Patients With Resected Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00059826 - Active, not recruiting
stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
- Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00006117 - Active, not recruiting
stage III pancreatic cancer; stage IV pancreatic cancer; adenocarcinoma of the pancreas
- Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00026403 - Active, not recruiting
stage III pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer
- Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00030732 - Active, not recruiting
stage III pancreatic cancer; recurrent pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00003546 - Active, not recruiting
stage III pancreatic cancer; adenocarcinoma of the pancreas; stage I pancreatic cancer; stage II pancreatic cancer
- Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00112528 - Active, not recruiting
duct cell adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer
- Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00010062 - Active, not recruiting
stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer
- Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00049348 - Active, not recruiting
adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer
- Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00112658 - Recruiting
adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Gemcitabine, Cisplatin, and Bevacizumab in Treating Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00126633 - Active, not recruiting
stage IVA pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
- MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00112580 - Recruiting
stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer; adenocarcinoma of the pancreas
- Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00026104 - Active, not recruiting
stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
- Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct
ClinicalTrials.gov Identifier: NCT00010088 - Active, not recruiting
adenocarcinoma of the extrahepatic bile duct; stage II pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; ...
- Irinotecan and Docetaxel With or Without Cetuximab in Treating Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00042939 - Active, not recruiting
adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00004861 - Active, not recruiting
stage II pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
- Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00003531 - Recruiting
recurrent pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00026130 - Active, not recruiting
stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
- Flavopiridol Plus Radiation Therapy Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00047307 - Recruiting
adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer
- Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00024427 - Active, not recruiting
adenocarcinoma of the pancreas; Drug Toxicity; Pancreatic Cancer
- Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00064207 - Active, not recruiting
adenocarcinoma of the pancreas; stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer
- Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00005871 - Active, not recruiting
recurrent pancreatic cancer; adenocarcinoma of the pancreas
- Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00033735 - Active, not recruiting
recurrent pancreatic cancer; duct cell adenocarcinoma of the pancreas
- Combination Chemotherapy Followed by Chemotherapy and Radiation Therapy and/or Surgery in Treating Patients Who Have Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00003332 - Active, not recruiting
stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
- 6-Hydroxymethylacylfulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00003760 - Active, not recruiting
recurrent pancreatic cancer; stage III pancreatic cancer; stage IV pancreatic cancer; adenocarcinoma of the pancreas
- Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00114179 - Active, not recruiting
adenocarcinoma of the pancreas; stage III pancreatic cancer; stage II pancreatic cancer
- Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00091026 - Recruiting
adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ...
- Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00005869 - Active, not recruiting
recurrent pancreatic cancer; stage II pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; ...
- Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00031837 - Active, not recruiting
adenocarcinoma of the pancreas; Pancreatic Cancer; Quality of Life; Thromboembolism
- Electroporation Therapy With Bleomycin in Treating Patients With Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00027521 - Active, not recruiting
stage III pancreatic cancer; adenocarcinoma of the pancreas
- Biological Therapy in Treating Patients With Stage I, Stage II, or Stage III Pancreatic Cancer That Has Been Surgically Removed
ClinicalTrials.gov Identifier: NCT00003434 - Active, not recruiting
stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
- Randomized Study Assessing the Effect of Transpapillary Pancreas Duct Stent in Resection of the Pancreatic Tail
ClinicalTrials.gov Identifier: NCT00500968 - Recruiting
Pancreas Cancer; Fistula
- Chemotherapy, Interferon alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00068575 - Recruiting
stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
- Gemcitabine With or Without R115777 in Treating Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00005648 - Active, not recruiting
recurrent pancreatic cancer; stage II pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; ...
- Gemcitabine With or Without Radiation Therapy in Treating Patients with Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00057876 - Active, not recruiting
stage III pancreatic cancer; adenocarcinoma of the pancreas
- Combination Chemotherapy, Celecoxib, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00089024 - Recruiting
adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer
- Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas
ClinicalTrials.gov Identifier: NCT00002955 - Active, not recruiting
stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00323583 - Recruiting
Adenocarincoma of Pancreas; Stage III Pancreatic Cancer; Stage IVA Pancreatic Cancer; Stage IVB Pancreatic Cancer
- Radiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00112697 - Recruiting
adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas
ClinicalTrials.gov Identifier: NCT00003810 - Completed
recurrent pancreatic cancer; stage III pancreatic cancer; stage IV pancreatic cancer; adenocarcinoma of the pancreas
- Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the Pancreas
ClinicalTrials.gov Identifier: NCT00003780 - Active, not recruiting
stage III pancreatic cancer; stage IV pancreatic cancer; Quality of Life; stage II pancreatic cancer
- Vaccine Therapy, Chemotherapy, and GM-CSF in Treating Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00002773 - Completed
stage III pancreatic cancer; recurrent pancreatic cancer; stage IVB pancreatic cancer; stage II pancreatic cancer; adenocarcinoma of the pancreas; ...
- Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas
ClinicalTrials.gov Identifier: NCT00003797 - Active, not recruiting
recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Phase I Study of Gemcitabine, Sorafenib and Radiotherapy in Patients With Unresectable Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00375310 - Recruiting
Pancreatic Cancer; Adenocarcinoma of the Pancreas
- Outcome of Pancreatic Stump Closure Following Resection of Tumors of the Head of the Pancreas.
ClinicalTrials.gov Identifier: NCT00419614 - Not yet recruiting
Pancreatic Neoplasms
- Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
ClinicalTrials.gov Identifier: NCT00006467 - Completed
recurrent pancreatic cancer; stage IVA pancreatic cancer; duct cell adenocarcinoma of the pancreas; stage III pancreatic cancer; ...
- Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00366457 - Recruiting
Pancreatic Cancer; Adenocarcinoma of the Pancreas
- Preop Chemoradiation Resectable Pancreas
ClinicalTrials.gov Identifier: NCT00336648 - Active, not recruiting
Pancreatic Neoplasms
- UCN-01 and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00039403 - Completed
stage II pancreatic cancer; stage III pancreatic cancer; recurrent pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; ...
- Cetuximab Plus Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Pancreas
ClinicalTrials.gov Identifier: NCT00005591 - Completed
stage III pancreatic cancer; Quality of Life; adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage IVA pancreatic cancer; ...
- Perifosine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00059982 - Completed
adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- UCN-01 and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00045747 - Completed
adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage IVB pancreatic cancer
- Bevacizumab and Gemcitabine in Treating Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00028834 - Completed
stage III pancreatic cancer; recurrent pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Gemcitabine Plus Oxaliplatin in Treating Patients With Refractory Locally Advanced or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00004190 - Completed
recurrent pancreatic cancer; stage IVA pancreatic cancer; duct cell adenocarcinoma of the pancreas; stage III pancreatic cancer; ...
- Perifosine in Treating Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00053924 - Completed
recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; stage II pancreatic cancer; adenocarcinoma of the pancreas; ...
- Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00002689 - Completed
stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
- BMS-247550 in Treating Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00016965 - Completed
stage II pancreatic cancer; stage III pancreatic cancer; recurrent pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; ...
- Gene Therapy Combined With Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer That Cannot Be Surgically Removed
ClinicalTrials.gov Identifier: NCT00049647 - No longer recruiting
adenocarcinoma of the pancreas; stage III pancreatic cancer
- R115777 in Treating Patients Who Have Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00005843 - Completed
recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
- Erlotinib, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00063947 - Completed
adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage III pancreatic cancer; stage II pancreatic cancer
- Vaccine Therapy Combined With Adjuvant Chemoradiotherapy in Treating Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas
ClinicalTrials.gov Identifier: NCT00084383 - Completed
stage I pancreatic cancer; stage II pancreatic cancer; duct cell adenocarcinoma of the pancreas
- Hyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas Cancer
ClinicalTrials.gov Identifier: NCT00178763 - Recruiting
Pancreatic Neoplasms
- Cancer of the Pancreas Screening Study (CAPS 3)
ClinicalTrials.gov Identifier: NCT00438906 - Recruiting
Pancreatic Neoplasm; Peutz-Jeghers Syndrome
- Bortezomib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00052689 - Completed
stage IVA pancreatic cancer; duct cell adenocarcinoma of the pancreas; stage IVB pancreatic cancer
- 3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00064051 - Active, not recruiting
stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer
- Pilot Study Using Neoadjuvant Chemo-Radiotherapy and Tarceva for Potentially Resectable Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00216307 - Not yet recruiting
adenocarcinoma of the pancreas
- A Phase 1-2, XIAP Antisense AEG35156 With Gemcitabine in Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00557596 - Recruiting
Carcinoma; Pancreas
- Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00032175 - Completed
stage III pancreatic cancer; duct cell adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the Pancreas
ClinicalTrials.gov Identifier: NCT00220649 - Recruiting
Pancreatic Neoplasms
Resources
- Helping Hand Resource Guide (Cancer Care, Inc.)
- Pancreas (National Institute of Diabetes and Digestive and Kidney Diseases)
email this page
print this page
bookmark this page
feedback on this page
